Effects of indomethacin on the rat small intestinal mucosa: Immunohistochemical and biochemical studies using anti-mucin monoclonal antibodies

Journal of Gastroenterology

Volumn 44, Issue 4, 2009, Pages 277-284

  Iwai, Tomohisa ^a   Ichikawa, Takafumi ^a   Goso, Yukinobu ^b   Ikezawa, Tomoaki ^a   Saegusa, Yoichi ^a   Okayasu, Isao ^a   Saigenji, Katsunori ^a   Ishihara, Kazuhiko ^b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Monoclonal antibody; NSAIDs; Sialomucin; Small intestine

Indexed keywords

INDOMETACIN; MONOCLONAL ANTIBODY; MUCIN; MUCIN 2; SIALOMUCIN;

ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE EPITHELIUM; INTESTINE INJURY; JEJUNUM ULCER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE MUCOSA; TISSUE REGENERATION; WOUND HEALING;

EID: 84940363565     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0007-0     Document Type: Article

References (33)

1. Walker WA. Development of the intestinal mucosal barrier. J Pediatr Gastroenterol Nutr. 2002;34(Suppl 1):S33-9.
2. Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S, Pignatelli M. Mucins and mucosal protection in the gastrointestinal tract: New prospects for mucins in the pathology of gastrointestinal disease. Gut. 2000;47:589-94.
3. Takeuchi K, Miyazawa T, Tanaka A, Kato S, Kunikata T. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion. 2002;66:30-41.
4. Tanaka A, Matsumoto M, Hayashi Y, Takeuchi K. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: Relation to intestinal hypermotility. J Gastroenterol Hepatol. 2005;20:38-45.
5. Satoh H, Guth PH, Grossman MI. Role of food in gastrointestinal ulceration produced by indomethacin in the rat. Gastroenterology. 1982;83:210-5.
6. Evans SM, Whittle BJ. Role of bacteria and inducible nitric oxide synthase activity in the systemic inflammatory microvascular response provoked by indomethacin in the rat. Eur J Pharmacol. 2003;461:63-71.
7. Hagiwara M, Kataoka K, Arimochi H, Kuwahara T, Ohnishi Y. Role of unbalanced growth of gram-negative bacteria in ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug. J Med Invest. 2004;51:43-51.
8. Reuter BK, Davies NM, Wallace JL. Nonsteroidal anti-inflammatory drug enteropathy in rats: Role of permeability, bacteria, and enterohepatic circulation. Gastroenterology. 1997;112:109-17.
9. Hollander F. The two-component mucous barrier; its activity in protecting the gastroduodenal mucosa against peptic ulceration. AMA Arch Intern Med. 1954;93:107-20.
10. Menguy R. Gastric mucus and the gastric mucous barrier. A review. Am J Surg. 1969;117:806-12.
11. Allen A. Structure of gastrointestinal mucus glycoproteins and the viscous and gel-forming properties of mucus. Br Med Bull. 1978;34:28-33.
12. Keshav S, Lawson L, Chung LP, Stein M, Perry VH, Gordon S. Tumor necrosis factor mRNA localized to Paneth cells of normal murine intestinal epithelium by in situ hybridization. J Exp Med. 1990;171:327-32.
13. Molmenti EP, Perlmutter DH, Rubin DC. Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest. 1993;92:2022-34.
14. Peeters T, Vantrappen G. The Paneth cell: A source of intestinal lysozyme. Gut. 1975;16:553-8.
15. Meyer-Hoffert U, Hornef MW, Henriques-Normark B, Axelsson LG, Midtvedt T, Putsep K, Andersson M. Secreted enteric antimicrobial activity localizes to the mucus surface layer. Gut. 2008;57:764-71.
16. Azuumi Y, Ohara S, Ishihara K, Okabe H, Hotta K. Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. Gut. 1980;21:533-6.
17. Ikezawa T, Ichikawa T, Adachi K, Sugano S, Ojima T, Nakamura Y, et al. Analysis of mucin composition in gastric juices of chronic rheumatic patients with upper gastrointestinal damage. Biomed Res. 2005;26:147-51.
18. Kojima Y, Ishihara K, Komuro Y, Saigenji K, Hotta K. Effects of the muscarinic receptor agonist carbachol and/or antagonist pirenzepine on gastric mucus secretion in rats. Scand J Gastroenterol. 1993;28:647-51.
19. Ikezawa T, Goso Y, Ichikawa T, Hayashida H, Kurihara M, Okayasu I, et al. Appearance of specific mucins recognized by monoclonal antibodies in rat gastric mucosa healing from HCl-induced gastric mucosal damage. J Gastroenterol. 2004;39:113-9.
20. Ishihara K, Kurihara M, Goso Y, Ota H, Katsuyama T, Hotta K. Establishment of monoclonal antibodies against carbohydrate moiety of gastric mucins distributed in the different sites and layers of rat gastric mucosa. Glycoconj J. 1996;13:857-64.
21. Ikezawa T, Goso Y, Ichikawa T, Hayashida H, Nakamura T, Kurihara M, et al. Immunohistochemical localization in rat gastrointestinal tract of a sialomucin species recognized by HCM31, a new anti-mucin monoclonal antibody. Biomed Res. 2002;23:63-8.
22. Tsubokawa D, Goso Y, Sawaguchi A, Kurihara M, Ichikawa T, Sato N, et al. A monoclonal antibody, PGM34, against 6-sulfated blood-group H type 2 antigen, on the carbohydrate moiety of mucin. FEBS J. 2007;274:1833-48.
23. Anthony A, Dhillon AP, Thrasivoulou C, Pounder RE, Wakefield AJ. Pre-ulcerative villous contraction and microvascular occlusion induced by indomethacin in the rat jejunum: A detailed morphological study. Aliment Pharmacol Ther. 1995;9:605-13.
24. Wax J, Clinger WA, Varner P, Bass P, Winder CV. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology. 1970;58:772-80.
25. Anthony A, Pounder RE, Dhillon AP, Wakefield AJ. Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin. Gut. 1997;41:763-70.
26. Saegusa Y, Ichikawa T, Iwai T, Goso Y, Okayasu I, Ikezawa T, Shikama N, Saigenji K, Ishihara K. Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis. Scand J Gastroenterol. 2008;43:59-65.
27. Kato S, Tanaka A, Kunikata T, Umeda M, Takeuchi K. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons. Digestion. 2000;61:39-46.
28. Hatazawa R, Ohno R, Tanigami M, Tanaka A, Takeuchi K. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats. J Pharmacol Exp Ther. 2006;318:691-9.
29. Azuumi Y, Ishihara K, Ohara S, Okabe H, Hotta K. Efficacy of anti-ulcer drugs on the recovery of gastric mucosal glycoproteins with aspirin-induced gastric damage in rat. Gastroenterol Jpn. 1981;16:331-4.
30. Kojima Y, Ishihara K, Ohara S, Saigenji K, Hotta K. Effects of the M1 muscarinic receptor antagonist pirenzepine on gastric mucus glycoprotein in rats with or without ethanol-induced gastric damage. Scand J Gastroenterol. 1992;27:764-8.
31. Yusuf S, Nok AJ, Ameh DA, Adelaiye AB, Balogun EO. Correlation of gastric mucosal damage with sialic acid profile in rats: Effect of hydrochloric acid, pepsin and hypertonic saline. Cell Biochem Funct. 2005;23:339-45.
32. Ho SB, Takamura K, Anway R, Shekels LL, Toribara NW, Ota H. The adherent gastric mucous layer is composed of alternating layers of MUC5AC and MUC6 mucin proteins. Dig Dis Sci. 2004;49:1598-606.
33. Matsuo K, Ota H, Akamatsu T, Sugiyama A, Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon. Gut. 1997;40:782-9.